CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-15 | BATE KENNETH Director | Sale | −896 | $368.56 | $330K | 2,627 |
| 2025-08-15 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2025-08-13 | FRIEDMAN PAUL A Director | Option exercise 10b5-1 | +129,172 | $9.45 | $1.2M | 316,336 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −1,600 | $358.23 | $573K | 314,736 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −455 | $359.31 | $163K | 314,281 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −3,153 | $360.27 | $1.1M | 311,128 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −1,754 | $361.13 | $633K | 309,374 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −1,439 | $362.29 | $521K | 307,935 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −2,591 | $363.08 | $941K | 305,344 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −3,529 | $364.02 | $1.3M | 301,815 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −1,716 | $365.19 | $627K | 300,099 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −3,152 | $366.22 | $1.2M | 296,947 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −7,119 | $367.31 | $2.6M | 289,828 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −6,788 | $368.34 | $2.5M | 283,040 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −7,992 | $369.44 | $3.0M | 275,048 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −7,877 | $370.44 | $2.9M | 267,171 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −22,710 | $371.53 | $8.4M | 244,461 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −28,976 | $372.39 | $10.8M | 215,485 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −24,166 | $373.35 | $9.0M | 191,319 |
| 2025-08-13 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −4,155 | $374.38 | $1.6M | 187,164 |
Page 18 of 82 · 1,629 trades